MedPath
FDA Approval

Lidocaine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
December 15, 2011
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Lidocaine(20 mg in 1 mL)
Epinephrine(0.02 mg in 1 mL)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Novocol Pharmaceutical of Canada, Inc.

Novocol Pharmaceutical of Canada, Inc.

Novocol Pharmaceutical of Canada, Inc.

201719960

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine

Product Details

NDC Product Code
51004-0550
Application Number
ANDA088389
Marketing Category
ANDA (C73584)
Route of Administration
SUBCUTANEOUS
Effective Date
December 15, 2011
LidocaineActive
Code: V13007Z41AClass: ACTIBQuantity: 20 mg in 1 mL
Code: 30Q7KI53AKClass: ACTIMQuantity: 0.02 mg in 1 mL
Sodium ChlorideInactive
Code: 451W47IQ8XClass: IACTQuantity: 6.5 mg in 1 mL
Potassium MetabisulfiteInactive
Code: 65OE787Q7WClass: IACTQuantity: 1.2 mg in 1 mL
Edetate DisodiumInactive
Code: 7FLD91C86KClass: IACTQuantity: 0.25 mg in 1 mL
Sodium HydroxideInactive
Code: 55X04QC32IClass: IACT
WaterInactive
Code: 059QF0KO0RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath